ABSTRACT
Background Disturbance of iron homeostasis in both the brain and blood is linked to cognitive impairment and neurodegenerative diseases. Investigation of the associations between changes in blood measurements and the accompanying structural changes in the brain, represented by susceptibility-weighted imaging, would generate evidence of a shared physiopathology between modalities, however linear approaches using derived imaging measures have not detected this relationship.
Method Brain SWI of 4436 participants from UK Biobank at the first imaging visit were used to build a convolutional neural network (CNN) predicting the haemoglobin level. Haemoglobin concentration was grouped in three sets percentiles creating prediction classes. Attention maps were extracted from the CNN using Integrated Gradients to identify which brain regions allowed the CNN to correctly classify haemoglobin.
Results The model predicted haemoglobin level >99% accuracy for three classes and >85% accuracy for ten classes. Using attention maps to understand the model’s decision process, we identified regions of interest for the 3-class model. Four out of the nine regions were located in the cerebral cortex. Changes in the right thalamus and the white matter tracts between the temporal gyrus, putamen, hippocampus, and thalamus regions were associated to high haemoglobin class.
Conclusion Our model accurately predicted haemoglobin levels from SWI suggesting an association between the iron measures. Furthermore, it was possible to identify brain areas used by the CNN for decision-making. Using this integrated model of iron modalities will give a more comprehensive view of iron homeostasis and the potential associations with neurodegenerative diseases such as dementia.
Competing Interest Statement
ANH has funding support from Ono Pharmaceuticals. All other authors declare no competing interests.
Funding Statement
LW was funded by Alzheimer's Research UK (ARUK-RF2020A-005). JS was funded by the scholarship of the protestant church in Germany Villigst.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were originally located at: UK Biobank.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.